Compare · LRCX vs TMO
LRCX vs TMO
Side-by-side comparison of Lam Research Corporation (LRCX) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- LRCX operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- LRCX is the larger of the two at $432.74B, about 1.7x TMO ($250.23B).
- TMO has been more active in the news (7 items in the past 4 weeks vs 4 for LRCX).
- Both have 25 recent analyst ratings on file.
- Company
- Lam Research Corporation
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $432.74B
- $250.23B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 1984
- News (4w)
- 4
- 7
- Recent ratings
- 25
- 25
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest LRCX
- Lam Research Corporation Announces September Quarter Financial Conference Call
- SEC Form DEFA14A filed by Lam Research Corporation
- SEC Form DEF 14A filed by Lam Research Corporation
- Wafer Inspection Equipment Market Growth — Why AI Chip Production Is Driving Demand
- President and CEO Archer Timothy exercised 30,000 shares at a strike of $30.03 and sold $9,577,800 worth of shares (30,000 units at $319.26) as part of a pre-agreed trading plan (SEC Form 4)
- Director Mayer Bethany sold $3,007,970 worth of shares (9,557 units at $314.74) (SEC Form 4)
- Senior Vice President Varadarajan Seshasayee sold $17,406,370 worth of shares (59,750 units at $291.32) as part of a pre-agreed trading plan and exercised 39,750 shares at a strike of $39.25, decreasing direct ownership by 9% to 205,546 units (SEC Form 4)
- Chief Legal Officer Harter Ava sold $1,512,300 worth of shares (5,000 units at $302.46) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 42,462 units (SEC Form 4)
- Lam Research Announces Retirement of Michael R. Cannon and Sohail U. Ahmed from Board of Directors
- Lam Research Corporation filed SEC Form 8-K: Leadership Update
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)